158 related articles for article (PubMed ID: 38027150)
21. [Expression and significance of serum E-cadherin in patients with papillary thyroid carcinoma].
Sun L; Wang DM; Zhang WJ; Zhang J; Wu JF
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Jan; 31(2):123-126. PubMed ID: 29871201
[No Abstract] [Full Text] [Related]
22. Male sex is associated with aggressive behaviour and poor prognosis in Chinese papillary thyroid carcinoma.
Ding J; Wu W; Fang J; Zhao J; Jiang L
Sci Rep; 2020 Mar; 10(1):4141. PubMed ID: 32139703
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein A1 is negatively associated with male papillary thyroid cancer patients: a cross-sectional study of single academic center in China.
Ma M; Wang M; Zhang Z; Lin B; Sun Z; Guan H; Lv W; Li J
BMC Endocr Disord; 2021 Apr; 21(1):69. PubMed ID: 33853556
[TBL] [Abstract][Full Text] [Related]
24. Analysis of factors influencing cervical lymph node metastasis of papillary thyroid carcinoma at each lateral level.
Liu WQ; Yang JY; Wang XH; Cai W; Li F
BMC Surg; 2022 Jun; 22(1):228. PubMed ID: 35701785
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of the role of prophylactic bilateral central neck lymph node dissection in patients with papillary thyroid carcinoma: a case controlled study.
Shahriarirad R; Meshkati Yazd SM; Zahedi R; Mokhtari Ardekani A; Rekabi MM; Nasiri S
Updates Surg; 2023 Apr; 75(3):679-689. PubMed ID: 36527603
[TBL] [Abstract][Full Text] [Related]
26. Risk and Prognostic Factors for BRAF
Wei X; Wang X; Xiong J; Li C; Liao Y; Zhu Y; Mao J
Biomed Res Int; 2022; 2022():9959649. PubMed ID: 35647194
[TBL] [Abstract][Full Text] [Related]
27. High iodine intake and central lymph node metastasis risk of papillary thyroid cancer.
Zhao H; Li H; Huang T
J Trace Elem Med Biol; 2019 May; 53():16-21. PubMed ID: 30910201
[TBL] [Abstract][Full Text] [Related]
28. Progression of solitary and multifocal papillary thyroid carcinoma - a retrospective study of 368 patients.
Zheng XQ; Wang C; Xu M; Yu Y; Yun XW; Jia YS; Wei SF; Ren XB; Gao M
Chin Med J (Engl); 2012 Dec; 125(24):4434-9. PubMed ID: 23253715
[TBL] [Abstract][Full Text] [Related]
29. Serum Adiponectin and Progranulin Level in Patients with Benign Thyroid Nodule or Papillary Thyroid Cancer.
Kwon H; Park SE; Yun JS; Park CY
Endocrinol Metab (Seoul); 2020 Jun; 35(2):396-406. PubMed ID: 32615724
[TBL] [Abstract][Full Text] [Related]
30. Coexistence of papillary thyroid carcinoma in secondary hyperparathyroidism.
Ma J; Mao Z; Yao Y; Lu Y; Wang H; Yang Y; Yang J; Wang W; Teng L
BMC Surg; 2021 Sep; 21(1):335. PubMed ID: 34488715
[TBL] [Abstract][Full Text] [Related]
31. [Clinical and pathological differences between papillary thyroid carcinoma with Graves' disease and papillary thyroid carcinoma with Hashimoto's thyroiditis].
Xu DD; Lun Y; Liu X; Jiang H; Song JB; Duan ZQ; Xin SJ; Zhang J
Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(32):2491-2495. PubMed ID: 28835054
[No Abstract] [Full Text] [Related]
32. Multifocal Papillary Thyroid Cancer Increases the Risk of Central Lymph Node Metastasis.
Al Afif A; Williams BA; Rigby MH; Bullock MJ; Taylor SM; Trites J; Hart RD
Thyroid; 2015 Sep; 25(9):1008-12. PubMed ID: 26161997
[TBL] [Abstract][Full Text] [Related]
33. Prevalence and impact of non-alcoholic fatty liver disease in patients with papillary thyroid carcinoma.
Xiao R; Ni C; Cai Y; Zhou Y; Gong X; Xie K; You J
Endocrine; 2023 Jun; 80(3):619-629. PubMed ID: 36696026
[TBL] [Abstract][Full Text] [Related]
34. Risk factors of central lymph node metastasis of papillary thyroid carcinoma: A single-center retrospective analysis of 3273 cases.
Liu W; Cheng R; Su Y; Diao C; Qian J; Zhang J; Ma Y; Fan Y
Medicine (Baltimore); 2017 Oct; 96(43):e8365. PubMed ID: 29069024
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis.
Cho JG; Byeon HK; Oh KH; Baek SK; Kwon SY; Jung KY; Woo JS
Eur Arch Otorhinolaryngol; 2018 Sep; 275(9):2355-2361. PubMed ID: 30019191
[TBL] [Abstract][Full Text] [Related]
36. Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer.
Qu N; Zhang L; Wu WL; Ji QH; Lu ZW; Zhu YX; Lin DZ
Tumour Biol; 2016 Jul; 37(7):8783-9. PubMed ID: 26743781
[TBL] [Abstract][Full Text] [Related]
37. Thirty synchronous medullary and papillary thyroid carcinomas.
Zhang D; Yang M; Zhang X; Wang C; Li K; Wang H; Chi H; Sui C; Dionigi G; Sun H
Front Endocrinol (Lausanne); 2023; 14():1153248. PubMed ID: 37065753
[TBL] [Abstract][Full Text] [Related]
38. Correlation among the BRAF gene mutation status, clinicopathological features of primary tumour, and lymph node metastasizing of papillary thyroid carcinoma.
Lukas J; Drabek J; Dudesek B; Vazan P; Stranska J; Jancik S; Mackova M; Syrucek M; Lukas D; Duskova J; Dundr P; Hintnausova B; Jiskra J
Exp Clin Endocrinol Diabetes; 2014 May; 122(5):268-72. PubMed ID: 24839220
[TBL] [Abstract][Full Text] [Related]
39. Bilateral multifocality is an independent predictor of patients' outcome in Middle Eastern papillary thyroid carcinoma.
Parvathareddy SK; Siraj AK; Annaiyappanaidu P; Siraj N; Al-Sobhi SS; Al-Dayel F; Al-Kuraya KS
Front Endocrinol (Lausanne); 2022; 13():1060301. PubMed ID: 36686467
[TBL] [Abstract][Full Text] [Related]
40. Association of multifocality, tumor number, and total tumor diameter with clinicopathological features in papillary thyroid cancer.
Tam AA; Özdemir D; Çuhacı N; Başer H; Aydın C; Yazgan AK; Ersoy R; Çakır B
Endocrine; 2016 Sep; 53(3):774-83. PubMed ID: 27090526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
